10月6日 - ** Personalis（PSNL.O）股价下跌约2%，至16.12美元
** BTIG将这家癌症检测厂商的评级从“买入”下调至“中性”
** 该券商表示，Tempus AI TEM.O 将在未来数月内完成对 PSNL 的收购；认为“尽管存在竞标过程”，但不会出现更高报价
** Tempus AI已同意于2026年7月收购Personalis (link)，交易估值约为15亿美元
** 5家券商中有1家给予该股“强烈买入”评级，4家给予“持有”评级，目标价中位数为16.25美元——数据由LSEG汇编
** 计入本交易日涨幅，该股今年以来累计上涨104.40%
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.